Form 4: Amylyx Pharmaceuticals Director Zeiher Acquires 10,000 Shares

Director Bernhardt G. Zeiher of Amylyx Pharmaceuticals, Inc. purchased 10,000 shares of common stock at a weighted average price of $3.7005 on March 20, 2025.

Summary

• On March 20, 2025, Bernhardt G. Zeiher, a director of Amylyx Pharmaceuticals, Inc., acquired 10,000 shares of common stock.
• The shares were purchased at a weighted average price of $3.7005, with individual transactions ranging from $3.65 to $3.73.
• Following the transaction, Zeiher directly owns 10,000 shares of Amylyx Pharmaceuticals, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a stock purchase by a director, which can be seen as a mildly positive signal, but doesn't provide strong evidence for a bullish or bearish outlook.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into a company's prospects, as perceived by its executives and directors. This purchase by a director at Amylyx Pharmaceuticals is a routine transaction that is required to be reported to the SEC.

Stakeholder Impact

• The stock purchase by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Amylyx Pharmaceuticals, Director, Stock Purchase, Form 4, Beneficial Ownership, AMLX, Zeiher